Trastuzumab
Stock Recap #PipelineProspector

Pipeline Prospector April 2024: Indices dip amid muted Q1 results; Vertex acquires Alpine Immune for US$ 4.9 bn

Pharma indices had begun to recede in March. Their red streak accelerated in April with the Nasdaq B

Pipeline Prospector Feb 2022: Biotechs face cash crunch after stock market ‘bloodbath’

Our January 2022 update of the Pipeline Prospector highlighted how the Omicron variant of the novel